These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25646267)

  • 1. Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators.
    Flierl U; Nero TL; Lim B; Arthur JF; Yao Y; Jung SM; Gitz E; Pollitt AY; Zaldivia MT; Jandrot-Perrus M; Schäfer A; Nieswandt B; Andrews RK; Parker MW; Gardiner EE; Peter K
    J Exp Med; 2015 Feb; 212(2):129-37. PubMed ID: 25646267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides.
    Delierneux C; Donis N; Servais L; Wéra O; Lecut C; Vandereyken M; Musumeci L; Rahmouni S; Schneider J; Eble JA; Lancellotti P; Oury C
    J Thromb Haemost; 2017 May; 15(5):983-997. PubMed ID: 28296036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing state attenuates ectodomain shedding of GPVI while restoring adhesion capacities of stored platelets: evidence addressing the controversy around the effects of redox condition on thrombosis.
    Hosseini E; Solouki A; Roudsari ZO; Kargar F; Ghasemzadeh M
    J Thromb Thrombolysis; 2020 Jul; 50(1):123-134. PubMed ID: 32409937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxiredoxin II is an antioxidant enzyme that negatively regulates collagen-stimulated platelet function.
    Jang JY; Wang SB; Min JH; Chae YH; Baek JY; Yu DY; Chang TS
    J Biol Chem; 2015 May; 290(18):11432-42. PubMed ID: 25802339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxepin inhibits GPVI-dependent platelet Ca
    Geue S; Walker-Allgaier B; Eißler D; Tegtmeyer R; Schaub M; Lang F; Gawaz M; Borst O; Münzer P
    Am J Physiol Cell Physiol; 2017 Jun; 312(6):C765-C774. PubMed ID: 28404545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trowaglerix Venom Polypeptides As a Novel Antithrombotic Agent by Targeting Immunoglobulin-Like Domains of Glycoprotein VI in Platelet.
    Chang CH; Chung CH; Tu YS; Tsai CC; Hsu CC; Peng HC; Tseng YJ; Huang TF
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1307-1314. PubMed ID: 28596377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gintonin modulates platelet function and inhibits thrombus formation via impaired glycoprotein VI signaling.
    Irfan M; Jeong D; Saba E; Kwon HW; Shin JH; Jeon BR; Kim S; Kim SD; Lee DH; Nah SY; Rhee MH
    Platelets; 2019; 30(5):589-598. PubMed ID: 29870296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral administration of Bruton's tyrosine kinase inhibitors impairs GPVI-mediated platelet function.
    Rigg RA; Aslan JE; Healy LD; Wallisch M; Thierheimer ML; Loren CP; Pang J; Hinds MT; Gruber A; McCarty OJ
    Am J Physiol Cell Physiol; 2016 Mar; 310(5):C373-80. PubMed ID: 26659727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel NOX inhibitor 2-acetylphenothiazine impairs collagen-dependent thrombus formation in a GPVI-dependent manner.
    Vara D; Campanella M; Pula G
    Br J Pharmacol; 2013 Jan; 168(1):212-24. PubMed ID: 22881838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet adhesion enhances the glycoprotein VI-dependent procoagulant response: Involvement of p38 MAP kinase and calpain.
    Siljander P; Farndale RW; Feijge MA; Comfurius P; Kos S; Bevers EM; Heemskerk JW
    Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):618-27. PubMed ID: 11304481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo.
    Massberg S; Konrad I; Bültmann A; Schulz C; Münch G; Peluso M; Lorenz M; Schneider S; Besta F; Müller I; Hu B; Langer H; Kremmer E; Rudelius M; Heinzmann U; Ungerer M; Gawaz M
    FASEB J; 2004 Feb; 18(2):397-9. PubMed ID: 14656994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary roles of glycoprotein VI and alpha2beta1 integrin in collagen-induced thrombus formation in flowing whole blood ex vivo.
    Kuijpers MJ; Schulte V; Bergmeier W; Lindhout T; Brakebusch C; Offermanns S; Fässler R; Heemskerk JW; Nieswandt B
    FASEB J; 2003 Apr; 17(6):685-7. PubMed ID: 12586747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand binding rapidly induces disulfide-dependent dimerization of glycoprotein VI on the platelet plasma membrane.
    Arthur JF; Shen Y; Kahn ML; Berndt MC; Andrews RK; Gardiner EE
    J Biol Chem; 2007 Oct; 282(42):30434-41. PubMed ID: 17690106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Snake venom metalloproteinases, crotarhagin and alborhagin, induce ectodomain shedding of the platelet collagen receptor, glycoprotein VI.
    Wijeyewickrema LC; Gardiner EE; Moroi M; Berndt MC; Andrews RK
    Thromb Haemost; 2007 Dec; 98(6):1285-90. PubMed ID: 18064326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reelin Amplifies Glycoprotein VI Activation and AlphaIIb Beta3 Integrin Outside-In Signaling via PLC Gamma 2 and Rho GTPases.
    Krueger I; Gremer L; Mangels L; Klier M; Jurk K; Willbold D; Bock HH; Elvers M
    Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2391-2403. PubMed ID: 32787521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycoprotein VI (GPVI)-functionalized nanoparticles targeting arterial injury sites under physiological flow.
    Levi M; Epshtein M; Castor T; Gawaz M; Korin N
    Nanomedicine; 2020 Oct; 29():102274. PubMed ID: 32712174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSK669, a NOD2 receptor antagonist, inhibits thrombosis and oxidative stress via targeting platelet GPVI.
    Pan G; Chang L; Zhang J; Liu Y; Hu L; Zhang S; Zhang J; Qiao J; Jakopin Ž; Hu H; Dong J; Ding Z
    Biochem Pharmacol; 2021 Jan; 183():114315. PubMed ID: 33152345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adhesion and activation of human platelets induced by convulxin involve glycoprotein VI and integrin alpha2beta1.
    Jandrot-Perrus M; Lagrue AH; Okuma M; Bon C
    J Biol Chem; 1997 Oct; 272(43):27035-41. PubMed ID: 9341142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation-independent, antibody-mediated removal of GPVI from circulating human platelets: development of a novel NOD/SCID mouse model to evaluate the in vivo effectiveness of anti-human platelet agents.
    Boylan B; Berndt MC; Kahn ML; Newman PJ
    Blood; 2006 Aug; 108(3):908-14. PubMed ID: 16569773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CEACAM1 negatively regulates platelet-collagen interactions and thrombus growth in vitro and in vivo.
    Wong C; Liu Y; Yip J; Chand R; Wee JL; Oates L; Nieswandt B; Reheman A; Ni H; Beauchemin N; Jackson DE
    Blood; 2009 Feb; 113(8):1818-28. PubMed ID: 19008452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.